The president and chief executive officer of the Biotechnology Innovation Organization shared insights on his keynote speech delivered at MDA 2026, reflecting on the evolving rare disease ecosystem. [WATCH TIME: 3 minutes]
John Crowley
Advertisement
Articles by John Crowley
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA and EMA Accepts Regulatory Applications for Cemdisiran in Generalized Myasthenia Gravis
2
Insights on Vibrance-2 Study Results of Alixorexton in Narcolepsy Type 2: Richard K. Bogan, MD, FCCP, FAASM
3
FDA Clears Investigational New Drug Application for Remyelinating Agent PTD802 in Multiple Sclerosis
4
Bevacizumab Secures Approval in Japan as World's First Therapy for Neurofibromatosis Type 2
5